ALXN1007

DRUG2 trials

Sponsors

Alexion Pharmaceuticals, Inc.

Conditions

HealthyHealthy Subjects

Phase 1

Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects

CompletedNCT01454986

Alexion Pharmaceuticals, Inc.Healthy

Start: 2011-11-30End: 2013-10-31Updated: 2017-02-03

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects

CompletedNCT01883544

Alexion Pharmaceuticals, Inc.Healthy Subjects

Start: 2013-06-30End: 2014-01-31Updated: 2014-03-31